Image For Activity Cover
What You Need to Know Now About Pain Management As the Opioid Overdose Crisis Evolves
Raymond Dionne, DDS, MS, PhD, Professor of Cell Biology at the Center for Quantitative Medicine with the School of Medicine at the University of Connecticut; Dr. Dionne is a dentist and clinical pharmacologist who conducted clinical pain research at the NIH for over 25 years and, in parallel, practiced general dentistry part-time in the District of Columbia. He is currently a Professor of Cell Biology at the Center for Quantitative Medicine with the School of Medicine at the University of Connecticut
Target Audience
Dentists, Dental Team Members, Physicians, Nurses, Advanced Practice Providers, and Physician Assistantss.
Webinar Description
The opioid overdose epidemic continues, evolving and presenting ongoing challenges to practicing clinicians in today’s environment. Learn what is new and changing and how it applies to your clinical practice: dosing for over-the-counter combinations of ibuprofen and acetaminophen, how to achieve meaningful pain relief for your patients, and emerging information on the genetics of pain. This webinar will inform dentists and suggest how they can effectively stay current in managing their patients’ pain.
Educational Objectives

At the conclusion of this activity, learners should be able to:

  • Recognize the therapeutic advantages, increased risks and appropriate dosing for combinations of an NSAID and acetaminophen for the management of acute dental pain.
  • Practice the prevention and management of acute pain with minimal use of opioid-containing analgesics,
  • Differentiate meaningful pain relief from the patient’s perspective from the risks of exposure to opioids that may precipitate substance misuse in vulnerable individuals.
Availability: Retired
Cost: FREE
Credit Offered:
No Credit Offered
The content on this site is intended solely to inform and educate medical professionals. This site shall not be used for medical advice and is not a substitute for the advice or treatment of a qualified medical professional.

Funding for this initiative was made possible (in part) by grant nos. 1H79TI086770 and 1H79TI085588 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

For Buprenorphine Training Inquiries, email PCSS-MOUD.


Powered By